Abstract
Chronochemotherapy has been proposed as a promising modality to provide timely optimized medication to achieve maximum efficacy with minimum side effect for patients with non-small cell lung cancer for years. We collected the data of 11 clinical studies performed in China with the purpose to compare the difference between chronochemotherapy and traditional chemotherapy. Results showed that chronochemotherapy has a more favorable efficacy and safety than traditional chemotherapy.
Similar content being viewed by others
References
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–94.
Brodowicz T, Krzakowski M, Zwitter M, Tzekova V, Ramlau R, Ghilezan N, et al. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase iii trial. Lung Cancer. 2006;52:155–63.
Cappuzzo F, Ciuleanu T, Stelmakh L, Cicenas S, Szczesna A, Juhasz E, et al. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol. 2010;11:521–9.
Non small cell lung cancer. 2013, cited 2013-10-30. Available from: http://www.nccn.org/professionals/physician_gls/pdf/nscl.Pdf.
Nation Comprehensive Cancer Network (2013) non–small cell lung cancer (version 2.2014). Available: http://www.nccn.org/professionals/physician_gls/pdf/nscl.Pdf Accessed 21 Jan 2014.
Azzoli CG, Temin S, Giaccone G. 2011 focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage iv non-small-cell lung cancer. J Oncol Pract/Am Soc Clin Oncol. 2012;8:63–6.
Azzoli CG, Giaccone G, Temin S. American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage iv non-small-cell lung cancer. J Oncol Pract/Am Soc Clin Oncol. 2010;6:39–43.
D’Addario G, Felip E, Group EGW. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol: Off J Eur Soc Med Oncol/ESMO. 2009;20 Suppl 4:68–70.
Bareschino MA, Schettino C, Rossi A, Maione P, Sacco PC, Zeppa R, et al. Treatment of advanced non small cell lung cancer. J Thorac Dis. 2011;3:122–33.
Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer. 2009;9:886–96.
Levi F, Okyar A, Dulong S, Innominato PF, Clairambault J. Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol. 2010;50:377–421.
Levi F. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control: CCC. 2006;17:611–21.
Halberg F, Haus E, Cardoso SS, Scheving LE, Kuhl JF, Shiotsuka R, et al. Toward a chronochemotherapy of neoplasia: tolerance of treatment depends upon host rhythms. Experientia. 1973;29:909–34.
Mormont MC, Levi F. Circadian-system alterations during cancer processes: a review. International journal of cancer Journal international du cancer. 1997;70:241–7.
Huang XL, Fu CJ, Bu RF. Role of circadian clocks in the development and therapeutics of cancer. J Int Med Res. 2011;39:2061–6.
Takimoto CH. Chronomodulated chemotherapy for colorectal cancer: failing the test of time? Eur J Cancer. 2006;42:574–81.
Mormont MC, Levi F. Cancer chronochemotherapy: principles, applications, and perspectives. Cancer. 2003;97:155–69.
Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007;47:593–628.
Levi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, et al. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst. 1994;86:1608–17.
Focan C, Denis B, Kreutz F, Focan-Henrard D, Levi F. Ambulatory chronochemotherapy with 5-fluorouracil, folinic acid, and carboplatin for advanced non-small cell lung cancer. A phase ii feasibility trial. J Infus Chemother. 1995;5:148–52.
Vincenzi B, Santini D, La Cesa A, Tonini G. Cancer chronochemotherapy: principles, applications, and perspectives. Cancer. 2003;98:881–2. author reply 882–883.
Acknowledgments
This study was supported by a grant from the Jiangsu Health International Exchange Supporting Program (to Dr. Xiao-Dong Li).
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding authors
Additional information
Mei Ji and Xiao-Dong Li are the co-first authors.
Rights and permissions
About this article
Cite this article
Ji, M., Li, XD., Zhang, H. et al. Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China. Tumor Biol. 35, 12285–12292 (2014). https://doi.org/10.1007/s13277-014-2539-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-014-2539-z